Who has invested in Yueer Gene?

AstraZeneca, Panlin Capital are named among the investors backing Yueer Gene.

Yueer Gene Funding: $50M Raised, Series B (2022)

Yueer Gene funding overview

Yueer Gene has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2022. The round record for Yueer Gene runs through 2022; nothing later has been disclosed. Investors on record include AstraZeneca, Panlin Capital. 2 distinct backers are named across the disclosed rounds.

Yueer Gene at a glance

Total raised: $50M
Latest round: Series B
Latest round date: June 2022
Notable investors: AstraZeneca, Panlin Capital

Frequently asked about Yueer Gene funding

How much has Yueer Gene raised?: Yueer Gene has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Yueer Gene?: AstraZeneca, Panlin Capital are named among the investors backing Yueer Gene.
What was the latest Yueer Gene funding round?: The most recent disclosed round is a Series B, announced in June 2022.
Where is Yueer Gene based?: No headquarters location is disclosed for Yueer Gene.
When did Yueer Gene last raise?: The last disclosed Yueer Gene round closed in June 2022 at Series B.

Yueer Gene totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Yueer Gene Funding: $50M Raised, Series B (2022)

Yueer Gene funding overview

Yueer Gene at a glance

Frequently asked about Yueer Gene funding

Companies related to Yueer Gene (39)

Browse related funding lists (4)